About: Sydney E. Salmon

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Sydney E. Salmon Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	Lékař, hematolog, onkolog. Autor prací z oboru. (cs)
rdfs:label	Sydney E. Salmon (cs) Sydney E. Salmon (en) Sydney E. Salmon (sk)
skos:prefLabel	Sydney E. Salmon (cs) Sydney E. Salmon (en) Sydney E. Salmon (sk)
name	Sydney E. Salmon (cs) Sydney E. Salmon (en) Sydney E. Salmon (sk)
instance of	wds:Q112394379-D8D48D06-A70A-4EF1-B39D-ADD55E494DD7
NL CR AUT ID	wds:Q112394379-A3C13778-83E0-453D-8429-C13D20B71370
instance of	Homo sapiens
NL CR AUT ID	nlk20050165911
occupation	wds:Q112394379-37C364F5-2DA5-463D-92C5-1EC93332D1DD wds:Q112394379-4D925404-443D-4B4F-A815-CF27DB433BAE wds:Q112394379-E8D64F02-FB4D-401C-9AC4-D0A09811C121
KBR person ID	wds:Q112394379-FBD00EBB-77B9-452C-977B-5B2B9603E8EE
CiNii Research ID	wds:Q112394379-057A5C5C-68E3-459A-9F82-40FC9542DA79
NUKAT ID	wds:Q112394379-BC6BBD91-7543-487A-8463-9EBAD217D204
sex or gender	wds:Q112394379-af6b8a39-119a-4b9f-862b-8596ca5f5f3e
ISNI	wds:Q112394379-9F0C77D6-F0F5-4EB1-A444-304595D13F71
VIAF ID	wds:Q112394379-5000C814-AFAF-4C65-A826-2C1548E031AF
Library of Congress authority ID	wds:Q112394379-0D4FC965-44F1-48DA-AF48-1E9196CFA497
Bibliothèque nationale de France ID	wds:Q112394379-2B412D53-6EFB-4AC3-895D-76D25770B4D4
IdRef ID	wds:Q112394379-CD0278F9-48F9-4DEF-A4B5-96366A50C507
NACSIS-CAT author ID	wds:Q112394379-C292040A-DAE9-4E96-9E1C-919D275C3320
Prabook ID	wds:Q112394379-451CA223-4B7C-421C-9E07-AA1D721C5CA9
SHARE Catalogue author ID	wds:Q112394379-D2A4BB29-27BC-4573-9789-5927B4680ACB
date of birth	wds:Q112394379-5F68FB55-A7B3-4D60-B390-65245E2D474F
date of death	wds:Q112394379-2581284D-BF92-44E6-B490-7822549D43BE
family name	wds:Q112394379-B5E25A6D-4305-44CE-8FFA-B11C77036BF1
National Library of Israel J9U ID	wds:Q112394379-19BFDB60-16AB-4DE2-9F4B-BF4B98E0D575
CiNii Research ID	https://cir.nii.ac.jp/crid/1140282266529820160.rdf
VIAF ID	http://viaf.org/viaf/2534290
Library of Congress authority ID	http://id.loc.gov/authorities/names/n79034800
Bibliothèque nationale de France ID	http://data.bnf.fr/ark:/12148/cb122845583#about
IdRef ID	http://www.idref.fr/09494296X/id
NACSIS-CAT author ID	https://ci.nii.ac.jp/author/DA05382935#entity
occupation	oncologist hematologist physician
KBR person ID	14744721
CiNii Research ID	1140282266529820160
NUKAT ID	n2015146038
sex or gender	male
ISNI	0000000080818830
VIAF ID	2534290
Library of Congress authority ID	n79034800
Bibliothèque nationale de France ID	122845583
IdRef ID	09494296X
NACSIS-CAT author ID	DA05382935
Prabook ID	808334
SHARE Catalogue author ID	100642
date of birth	1936-01-01 00:00:00Z (xsd:dateTime)
date of death	1999-01-01 00:00:00Z (xsd:dateTime)
family name	Salmon
National Library of Israel J9U ID	987007345080505171
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q112394379
is author of	The current status and future prospects of treatment for multiple myeloma Polyamines as markers of response and disease activity in cancer chemotherapy Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321. Phase II study of carboplatin (CBDCA) in refractory multiple myeloma. A Southwest Oncology Group study Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitor Silicone gels, induction of plasma cell tumors, and genetic susceptibility in mice: a call for epidemiologic investigation of women with silicone breast implants P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy. Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer Evaluation of an automated image analysis system for counting human tumor colonies Primary Bioassay of Human Tumor Stem Cells Pretreatment tumor mass, cell kinetics, and prognosis in multiple myeloma. Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer Antitumor activity of esorubicin in human tumor clonogenic assay with comparisons to doxorubicin. Phase II trial of esorubicin (4' deoxydoxorubicin) in cancers of the breast, colon, kidney, lung and melanoma Phase I trial of esorubicin (4'deoxydoxorubicin). In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival High Speed Scintillation Autoradiography Dose response evaluation of adriamycin in human neoplasia Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms Amyloid production in human myeloma stem-cell culture, with morphologic evidence of amyloid secretion by associated macrophages Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs Indium-111 bleomycin tumor scanning in lymphoma Effects of suramin on in vitro growth of fresh human tumors Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group study Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model Effect of 13-cis-retinoic acid and 4-hydroxyphenyl-all-trans-retinamide on human tumor colony formation in soft agar Studies of the Combination of Adriamycin, and Cyclophosphamide (Alone or with other Agents) for the Treatment of Breast Cancer High-dose melphalan with autotransplantation for refractory multiple myeloma: results of a Southwest Oncology Group phase II trial Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. In vitro evaluation of chemosensitizers for clinical reversal of P-glycoprotein-associated Taxol resistance. Nabilone: a potent antiemetic cannabinol with minimal euphoria Evaluation of topotecan in resistant and relapsing multiple myeloma: a Southwest Oncology Group study Addition of cisplatin and bleomycin to vincristine-carmustine-doxorubicin-prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study Bleomycin pharmacokinetics in man. I. Intravenous administration Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study Inhibition of human melanoma colony formation by retinoids The human tumor clonogenic assay in human breast cancer. Quantitative association between the in vitro human tumor stem cell assay and clinical response to cancer chemotherapy

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software